• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种量化分析方法线性偏差的方法。

A method to quantify deviations from assay linearity.

作者信息

Krouwer J S, Schlain B

机构信息

Ciba Corning Diagnostics Corp., Medfield, MA 02052.

出版信息

Clin Chem. 1993 Aug;39(8):1689-93.

PMID:8353958
Abstract

We present a statistical method to quantify deviations from linearity for assays that veer from linear assay responses. Our procedure handles the common case of unequally spaced analyte levels and nonconstant variance and provides a least-squares estimate with a confidence interval for the amount of deviation from assay linearity at a specified analyte concentration. This estimate of assay bias due to nonlinearity goes beyond the NCCLS EP6 lack-of-fit test, which tests for only the presence of nonlinearity. Knowing that nonlinearity is present is insufficient; users need to know the magnitude of the bias caused by nonlinearity. Our method can also be used with multifactor designs that estimate other systematic assay effects such as drift and carryover, thus obviating the need for a separate protocol to assess linearity. The procedure is carried out by adding extra columns to the design matrix corresponding to the concentration level(s) of interest. The extra columns, which replace the quadratic column, are orthogonal to all other columns. We describe a general method of constructing the new columns, and illustrate the procedure with a manual ammonia assay example dataset from EP6.

摘要

我们提出了一种统计方法,用于量化线性检测响应出现偏差的检测方法与线性的偏离程度。我们的程序处理了分析物水平不等距和方差非恒定的常见情况,并提供了一个最小二乘估计值以及在指定分析物浓度下与检测线性度偏离量的置信区间。这种由于非线性导致的检测偏差估计超出了NCCLS EP6拟合不足检验,后者仅测试非线性的存在。仅仅知道存在非线性是不够的;用户需要知道由非线性引起的偏差大小。我们的方法还可用于估计其他系统检测效应(如漂移和残留)的多因素设计,从而无需单独的方案来评估线性度。该程序是通过在设计矩阵中添加与感兴趣的浓度水平相对应的额外列来执行的。这些取代二次列的额外列与所有其他列正交。我们描述了构建新列的一般方法,并用来自EP6的手动氨检测示例数据集说明了该程序。

相似文献

1
A method to quantify deviations from assay linearity.一种量化分析方法线性偏差的方法。
Clin Chem. 1993 Aug;39(8):1689-93.
2
A theoretical evaluation of linearity.
Clin Chem. 1993 Mar;39(3):405-13.
3
Preparation of samples with equally spaced concentrations through mixing.通过混合制备具有等间距浓度的样品。
Clin Chem. 1996 Jul;42(7):1074-8.
4
Testing assay linearity over a pre-specified range.在预先指定的范围内测试分析方法的线性。
J Biopharm Stat. 2015;25(2):339-50. doi: 10.1080/10543406.2014.972513.
5
A quantitative measure of nonlinearity.
Clin Chem. 1993 May;39(5):766-72.
6
Chemistry with confidence: should Clinical Chemistry require confidence intervals for analytical and other data?充满信心地看待化学:临床化学是否需要分析数据及其他数据的置信区间?
Clin Chem. 1993 Jun;39(6):929-35.
7
Evaluation of linearity in the clinical laboratory.临床实验室线性评估。
Arch Pathol Lab Med. 2004 Jan;128(1):44-8. doi: 10.5858/2004-128-44-EOLITC.
8
Correspondence of linearity evaluations to the performance of clinical chemistry instrument and reagent systems.
Arch Pathol Lab Med. 1992 Jul;116(7):761-4.
9
Axon clinical chemistry analyzer evaluated according to ECCLS protocol.
Clin Chem. 1992 Oct;38(10):2096-100.
10
"G" test and evaluation of assay linearity.
Clin Chem. 1990 Jul;36(7):1384.

引用本文的文献

1
A method for measuring the experimental resolution of laboratory assays (clinical biochemical, blood count, immunological, and qPCR) to evaluate analytical performance.一种用于测量实验室检测(临床生化、血常规、免疫学和 qPCR)的实验分辨率的方法,以评估分析性能。
J Clin Lab Anal. 2021 Dec;35(12):e24087. doi: 10.1002/jcla.24087. Epub 2021 Nov 1.
2
Analytical evaluation of the clonoSEQ Assay for establishing measurable (minimal) residual disease in acute lymphoblastic leukemia, chronic lymphocytic leukemia, and multiple myeloma.对 clonoSEQ 检测方法在急性淋巴细胞白血病、慢性淋巴细胞白血病和多发性骨髓瘤中建立可测量(最小)残留病的分析评估。
BMC Cancer. 2020 Jun 30;20(1):612. doi: 10.1186/s12885-020-07077-9.
3
Analytical validation of the Oncotype DX prostate cancer assay - a clinical RT-PCR assay optimized for prostate needle biopsies.
Oncotype DX 前列腺癌检测的分析验证——一种针对前列腺针吸活检优化的临床实时聚合酶链反应检测。
BMC Genomics. 2013 Oct 8;14:690. doi: 10.1186/1471-2164-14-690.
4
Translating tumor biology into personalized treatment planning: analytical performance characteristics of the Oncotype DX Colon Cancer Assay.将肿瘤生物学转化为个性化治疗计划:Oncotype DX 结肠癌检测的分析性能特征。
BMC Cancer. 2010 Dec 23;10:691. doi: 10.1186/1471-2407-10-691.